BACKGROUND: Extracorporeal life support (ECLS) is a circulatory assistance device that is increasingly used in adults undergoing cardiopulmonary arrest (CPA) or hemodynamic collapse when conventional therapies fail. OBJECTIVES: To assess the feasibility and outcomes of 100 consecutive arteriovenous percutaneous ECLS procedures at the Grenoble University Hospital between January 2002 and September 2007. METHODS: Monocentric descriptive registry with one-year prospective follow-up. RESULTS: An ECLS device was successfully used in 93% of patients. Its indication was cardiogenic shock in 50% of the cases, CPA in 38% of the cases and unsuccessful weaning of cardiopulmonary bypass (CPB) after cardiothoracic surgery in 12% of the cases. Direct complications of ECLS were observed in 56% of patients, the most frequent being hemorrhage at the intravenous puncture site requiring red blood cell transfusions (26%), and lower limb ischemia (19%). Weaning from ECLS was achieved in 33 patients (44% cardiogenic shocks, 13% CPAs, 50% CPB weaning failures) and 20 patients were discharged from the hospital (26% cardiogenic shocks, 10.5% CPAs and 25% CPB weaning failures). All are still living without any serious sequelae (mean follow-up period of 16.8 months). CONCLUSION: The use of ECLS in CPA patients, especially with cardiogenic shock, is feasible with satisfactory survival rates, given the extreme severity of their initial state.
BACKGROUND: Extracorporeal life support (ECLS) is a circulatory assistance device that is increasingly used in adults undergoing cardiopulmonary arrest (CPA) or hemodynamic collapse when conventional therapies fail. OBJECTIVES: To assess the feasibility and outcomes of 100 consecutive arteriovenous percutaneous ECLS procedures at the Grenoble University Hospital between January 2002 and September 2007. METHODS: Monocentric descriptive registry with one-year prospective follow-up. RESULTS: An ECLS device was successfully used in 93% of patients. Its indication was cardiogenic shock in 50% of the cases, CPA in 38% of the cases and unsuccessful weaning of cardiopulmonary bypass (CPB) after cardiothoracic surgery in 12% of the cases. Direct complications of ECLS were observed in 56% of patients, the most frequent being hemorrhage at the intravenous puncture site requiring red blood cell transfusions (26%), and lower limb ischemia (19%). Weaning from ECLS was achieved in 33 patients (44% cardiogenic shocks, 13% CPAs, 50% CPB weaning failures) and 20 patients were discharged from the hospital (26% cardiogenic shocks, 10.5% CPAs and 25% CPB weaning failures). All are still living without any serious sequelae (mean follow-up period of 16.8 months). CONCLUSION: The use of ECLS in CPA patients, especially with cardiogenic shock, is feasible with satisfactory survival rates, given the extreme severity of their initial state.
Authors: F D Pagani; W Lynch; F Swaniker; D B Dyke; R Bartlett; T Koelling; M Moscucci; G M Deeb; S Bolling; H Monaghan; K D Aaronson Journal: Circulation Date: 1999-11-09 Impact factor: 29.690
Authors: C Smith; R Bellomo; J S Raman; G Matalanis; A Rosalion; J Buckmaster; G Hart; W Silvester; G A Gutteridge; B Smith; L Doolan; B F Buxton Journal: Ann Thorac Surg Date: 2001-05 Impact factor: 4.330
Authors: J S Hochman; C E Buller; L A Sleeper; J Boland; V Dzavik; T A Sanborn; E Godfrey; H D White; J Lim; T LeJemtel Journal: J Am Coll Cardiol Date: 2000-09 Impact factor: 24.094
Authors: Y Hayashi; S Ohtake; Y Sawa; M Nishimura; H Ichikawa; H Satoh; T Yamaguchi; H Suhara; T Sakaguchi; H Matsuda Journal: Jpn J Thorac Cardiovasc Surg Date: 2000-05
Authors: B W Duncan; A E Ibrahim; V Hraska; P J del Nido; P C Laussen; D L Wessel; J E Mayer; L K Bower; R A Jonas Journal: J Thorac Cardiovasc Surg Date: 1998-08 Impact factor: 5.209
Authors: Mina Guirgis; Kanwal Kumar; Shelley Zieroth; Roger Philipp; Alan H Menkis; Darren H Freed Journal: Can J Cardiol Date: 2010-10 Impact factor: 5.223